E. Hommel

7.8k total citations · 2 hit papers
99 papers, 5.8k citations indexed

About

E. Hommel is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, E. Hommel has authored 99 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Nephrology, 37 papers in Endocrinology, Diabetes and Metabolism and 17 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in E. Hommel's work include Chronic Kidney Disease and Diabetes (39 papers), Diabetes Management and Research (24 papers) and Diabetes and associated disorders (13 papers). E. Hommel is often cited by papers focused on Chronic Kidney Disease and Diabetes (39 papers), Diabetes Management and Research (24 papers) and Diabetes and associated disorders (13 papers). E. Hommel collaborates with scholars based in Denmark, United States and United Kingdom. E. Hommel's co-authors include H.‐H. Parving, Elisabeth R. Mathiesen, U. Smidt, J. Giese, E. R. Mathiesen, Peter Rossing, Hans‐Henrik Parving, Hans‐Henrik Parving, U. Smidt and Berit Edsberg and has published in prestigious journals such as Gastroenterology, The Journal of Physical Chemistry B and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

E. Hommel

97 papers receiving 5.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of antihypertensive treatment on kidney function in diabetic nephropathy.

1987 401 citations Hans‐Henrik Parving, U. Smidt et al. BMJ profile →
The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial

2012 365 citations E. Hommel et al. Diabetologia profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
E. Hommel	2.8k	2.3k	1.9k	838	651	99	5.8k
Sylvia E. Rosas	2.2k 0.8×	2.0k 0.9×	1.2k 0.6×	1.2k 1.4×	341 0.5×	120	6.3k
R. J. Jarrett	4.5k 1.6×	1.7k 0.7×	2.3k 1.2×	1.1k 1.3×	740 1.1×	93	8.0k
Bo Feldt‐Rasmussen	3.3k 1.2×	4.2k 1.8×	3.5k 1.8×	1.4k 1.6×	794 1.2×	249	9.9k
Jens Brøchner‐Mortensen	2.5k 0.9×	3.4k 1.5×	3.3k 1.7×	769 0.9×	136 0.2×	85	7.3k
T. Deckert	5.3k 1.9×	3.7k 1.6×	2.7k 1.4×	1.6k 1.9×	1.6k 2.4×	176	10.4k
L. Lee Hamm	1.2k 0.4×	2.3k 1.0×	1.4k 0.7×	658 0.8×	199 0.3×	83	5.2k
Flavio Gaspari	952 0.3×	3.3k 1.4×	1.5k 0.8×	1.0k 1.2×	221 0.3×	128	7.1k
Thomas Philipp	1.2k 0.4×	1.4k 0.6×	2.0k 1.0×	1.7k 2.0×	133 0.2×	178	6.1k
David G. Warnock	1.2k 0.4×	2.5k 1.1×	1.3k 0.7×	637 0.8×	276 0.4×	88	6.6k
A. J. M. Donker	1.2k 0.4×	1.5k 0.6×	1.6k 0.8×	1.3k 1.5×	130 0.2×	128	5.8k

Countries citing papers authored by E. Hommel

Since Specialization

Citations

This map shows the geographic impact of E. Hommel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Hommel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Hommel more than expected).

Fields of papers citing papers by E. Hommel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Hommel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Hommel. The network helps show where E. Hommel may publish in the future.

Co-authorship network of co-authors of E. Hommel

This figure shows the co-authorship network connecting the top 25 collaborators of E. Hommel. A scholar is included among the top collaborators of E. Hommel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Hommel. E. Hommel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Suvitaival, Tommi, Henrik U. Andersen, E. Hommel, et al.. (2025). Metabolic Effects of Glucagon Stimulations in Type 1 Diabetes and Healthy Controls. The Journal of Clinical Endocrinology & Metabolism. 110(10). e3433–e3441. 1 indexed citations

Suvitaival, Tommi, Henrik U. Andersen, E. Hommel, et al.. (2024). Metabolic effect of adrenaline infusion in people with type 1 diabetes and healthy individuals. Diabetologia. 67(6). 1095–1106. 1 indexed citations

Schmidt, Signe, E. Hommel, Hans Perrild, et al.. (2020). Efficacy of Bolus Calculation and Advanced Carbohydrate Counting in Type 2 Diabetes: A Randomized Clinical Trial. Diabetes Technology & Therapeutics. 23(2). 95–103. 12 indexed citations

Hommel, E., et al.. (2019). Skin Problems Due to Treatment with Technology Are Associated with Increased Disease Burden Among Adults with Type 1 Diabetes. Diabetes Technology & Therapeutics. 21(4). 215–221. 21 indexed citations

Klefter, Oliver Niels, E. Hommel, Inger Christine Munch, et al.. (2016). Retinal characteristics during 1 year of insulin pump therapy in type 1 diabetes: a prospective, controlled, observational study. Acta Ophthalmologica. 94(6). 540–547. 15 indexed citations

Secher, Anna L., Lene Ringholm, Kirsten Nørgaard, et al.. (2013). Changes in basal rates and bolus calculator settings in insulin pumps during pregnancy in women with type 1 diabetes. The Journal of Maternal-Fetal & Neonatal Medicine. 27(7). 724–728. 38 indexed citations

Christensen, Tomas Møller, et al.. (2012). Duration of off-loading and recurrence rate in Charcot osteo-arthropathy treated with less restrictive regimen with removable walker. Journal of Diabetes and its Complications. 26(5). 430–434. 47 indexed citations

Due‐Christensen, Mette, et al.. (2011). Can sharing experiences in groups reduce the burden of living with diabetes, regardless of glycaemic control?. Diabetic Medicine. 29(2). 251–256. 34 indexed citations

Soja, Anne Merete Boas, Ann‐Dorthe Zwisler, Thomas Melchior, et al.. (2006). Prevalence and characteristics of impaired glucose metabolism in patients referred to comprehensive cardiac rehabilitation: the DANSUK study. European Journal of Cardiovascular Prevention & Rehabilitation. 13(5). 784–790. 6 indexed citations

10.

Hommel, E., et al.. (2002). Orosomucoid in urine predicts cardiovascular and over-all mortality in patients with Type II diabetes. Diabetologia. 45(1). 115–120. 37 indexed citations

11.

Parving, Hans-Henrik, E. Hommel, Berit R. Jensen, & Henrik Post Hansen. (2001). Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients. Kidney International. 60(1). 228–234. 74 indexed citations

12.

Hansen, Henrik Post, Peter Rossing, E. R. Mathiesen, et al.. (1998). Assessment of glomerular filtration rate in diabetic nephropathy using the plasma clearance of ⁵¹ Cr-EDTA. Scandinavian Journal of Clinical and Laboratory Investigation. 58(5). 405–414. 9 indexed citations

13.

Jensen, Jan Skov, Elisabeth R. Mathiesen, K. N�rgaard, et al.. (1990). Increased blood pressure and erythrocyte sodium/lithium countertransport activity are not inherited in diabetic nephropathy. Diabetologia. 33(10). 619–624. 84 indexed citations

14.

Parving, H.‐H. & E. Hommel. (1989). Prognosis in diabetic nephropathy.. BMJ. 299(6693). 230–233. 136 indexed citations

15.

Parving, H.‐H., E. Hommel, Meta Damkjær Nielsen, & J. Giese. (1989). Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy.. BMJ. 299(6698). 533–536. 138 indexed citations

16.

Parving, H.‐H., Michael Larsen, E. Hommel, & Henrik Lund‐Andersen. (1989). Effect of antihypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive Type 1 (insulin-dependent) diabetic patients with background retinopathy. Diabetologia. 32(7). 440–444. 49 indexed citations

17.

Mathiesen, E. R., M.‐A. Gall, E. Hommel, P. Skøtt, & H.‐H. Parving. (1989). Effects of Short‐term Strict Metabolic Control on Kidney Function and Extracellular Fluid Volume in Incipient Diabetic Nephropathy. Diabetic Medicine. 6(7). 595–600. 10 indexed citations

18.

Parving, H.‐H., E. Hommel, & U. Smidt. (1988). Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy.. BMJ. 297(6656). 1086–1091. 246 indexed citations

19.

Parving, H.-H., E. Hommel, Elisabeth R. Mathiesen, et al.. (1988). Prevalence of microalbuminuria, arterial hypertension, retinopathy, and neuropathy in patients with insulin dependent diabetes. BMJ. 296(6616). 156–160. 344 indexed citations

20.

Mathiesen, Elisabeth R., et al.. (1987). Surface Charge of Red Blood Cells in Insulin‐dependent Diabetic Patients with Incipient and Overt Nephropathy. Diabetic Medicine. 4(5). 431–433. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact